{"organizations": [], "uuid": "178a5a2c2d8ddfeea94e69fa9fb9e2b9ff2a5fb9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-may-23-idUSL5N1ST50I", "country": "US", "domain_rank": 408, "title": "Swiss stocks - Factors to watch on May 23", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-23T08:22:00.000+03:00", "replies_count": 0, "uuid": "178a5a2c2d8ddfeea94e69fa9fb9e2b9ff2a5fb9"}, "author": "", "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-may-23-idUSL5N1ST50I", "ord_in_thread": 0, "title": "Swiss stocks - Factors to watch on May 23", "locations": [], "entities": {"persons": [{"name": "andrea maechler", "sentiment": "none"}, {"name": "cara therapeutics", "sentiment": "none"}, {"name": "vifor pharma", "sentiment": "none"}], "locations": [{"name": "le temps", "sentiment": "none"}, {"name": "zurich", "sentiment": "none"}, {"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "lem holding", "sentiment": "none"}, {"name": "u.s. food and drug administrations", "sentiment": "none"}, {"name": "cosmo pharmaceuticals", "sentiment": "none"}, {"name": "national bank board", "sentiment": "none"}, {"name": "methylene blue", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 23, 2018 / 4:31 AM / in 8 minutes Swiss stocks - Factors to watch on May 23 Reuters Staff 2 Min Read\nZURICH, May 23 (Reuters) - The Swiss blue-chip SMI was seen opening 0.2 percent lower at 8,915 points on Wednesday, according to premarket indications by bank Julius Baer .\nHere are some of the main factors that may affect Swiss stocks: JULIUS BAER\nThe Swiss private bank on Wednesday said its assets under management rose 3 percent in the first four months of 2018 to 401 billion Swiss francs ($404 billion).\nFor more, click on COMPANY STATEMENTS\n* Cosmo Pharmaceuticals said that it received a complete response letter consistent with the U.S. Food and Drug Administrations’s feedback earlier thi smonth in which the agency determined it could not approve the company’s Methylene Blue.\n* LEM Holding said fourth-quarter net profit rose 28 percent to 15.3 million francs.\n* Vifor Pharma said it is working with Cara Therapeutics to develop an injection for a chronic kidney disease called associated pruritus.\n* CPH Chemie Und Papier Holding has acquired sales activities for molecular sieves in China from Shanghai Yusheng Chemical Co. Ltd. ECONOMY\n* Swiss National Bank Board Member Andrea Maechler said in Le Temps that if Swiss voters said yes to a sovereign money initiative on Sunday that could lead to inflation. Reporting by Zurich newsroom", "external_links": [], "published": "2018-05-23T08:22:00.000+03:00", "crawled": "2018-05-23T08:57:48.052+03:00", "highlightTitle": ""}